Search

Your search keyword '"Xiao-Ping Sheng"' showing total 3 results
Start Over Author "Xiao-Ping Sheng"
3 results on '"Xiao-Ping Sheng"'

1. Pharmacological effects of higenamine based on signalling pathways and mechanism of action

Author

De-ta Chen, Wu Rao, Xue Shen, Lin Chen, Zi-jian Wan, Xiao-ping Sheng, and Tian-you Fan

Subjects
higenamine, mechanism of action, pharmacological effect, signalling pathway, TCM, Therapeutics. Pharmacology, RM1-950
Abstract

Higenamine (HG) is a chemical compound found in various plants, such as aconite. Recent pharmacological studies have demonstrated its effectiveness in the management of many diseases. Several mechanisms of action of HG have been proposed; however, they have not yet been classified. This review summarises the signalling pathways and pharmacological targets of HG, focusing on its potential as a naturally extracted drug. Articles related to the pharmacological effects, signalling pathways and pharmacological targets of HG were selected by searching the keyword “Higenamine” in the PubMed, Web of Science and Google Scholar databases without limiting the search by publication years. HG possesses anti-oxidant, anti-apoptotic, anti-inflammatory, electrophysiology regulatory, anti-fibrotic and lipid-lowering activities. It is a structural analogue of catecholamines and possesses characteristics similar to those of adrenergic receptor ligands. It can modulate multiple targets, including anti-inflammation- and anti-apoptosis-related targets and some transcription factors, which directly or indirectly influence the disease course. Other naturally occurring compounds, such as cucurbitacin B (Cu B) and 6-gingerol (6-GR), can be combined with HG to enhance its anti-apoptotic activity. Although significant research progress has been made, follow-up pharmacological studies are required to determine the exact mechanism of action, new signalling pathways and targets of HG and the effects of using it in combination with other drugs.

Published
2022
Full Text
View/download PDF

2. To Explore the Mechanism of 'Fuzi-Guizhi' for the Treatment of Osteoarthritis on the Basis of Network Pharmacology and Molecular Docking

Author

Xue Shen, De-Ta Chen, Yu-Mei Li, Lin Chen, Yan-Bin Pan, Xiao-Ping Sheng, Wu Rao, Xiao-Liang Xie, Jing-Liang Gu, Hai-Xia Zhu, Tian-You Fan, and Min-Lei Qiu

Subjects
Organic Chemistry, Drug Discovery, General Medicine, Computer Science Applications
Abstract

Objective: The objective of this study is to analyze and verify the main drug components and targets of "Fuzi-Guizhi" in the treatment of osteoarthritis by using the network pharmacology platform. Methods: The integrated pharmacology of "Fuzi-Guizhi" was analyzed by using the platform of integrated pharmacology of traditional Chinese medicine to explore its mechanism in the treatment of osteoarthritis. By establishing an arthritis model in vitro, the pharmacological effect of "aconitecassia twigs" on articular cartilage was evaluated and conducted for molecular docking. Results: 28 candidate active components, 37 compound targets, and 583 osteoarthritis-related potential targets were screened, and 10 key target processes were screened in the protein interaction network model. Enrichment analysis showed that the 10 core targets involved 958 GO biologic function items and 76 KEGG signal pathways, which were mainly related to apoptosis and mitochondrial functional metabolism. And "Fuzi-Guizhi" drug-containing serum inhibited the expression of Caspase-3 mRNA and protein in chondrocytes and promoted the synthesis of ATP. Conclusion: Our research is preliminary that the mechanism of action of "Fuzi-Guizhi" may inhibit chondrocyte degeneration by resisting mitochondrial apoptosis, and further experimental research is required to determine.

Published
2023
Full Text
View/download PDF

3. [Comparative observation on hip osteoarthritis treated with electroacupuncture and medication]

Author

Xiao-Ping, Sheng and Tian-You, Fan

Subjects
Adult, Aged, 80 and over, Male, Diclofenac, Anti-Inflammatory Agents, Non-Steroidal, Pain, Middle Aged, Osteoarthritis, Hip, Electroacupuncture, Treatment Outcome, Humans, Pain Management, Female, Aged
Abstract

To observe the differences of effect of electroacupuncture and medication on hip osteoarthritis.Sixty cases were randomly divided into an electroacupuncture group and a medication group, 30 cases in each one. In electroacupuncture group, electroacupuncture was applied at Biguan (ST 31), Juliao (GB 29), Zuwuli (LR 10) and Yinlian (LR 11). In medication group, Diclofenac Sodium was prescribed for oral administration. One month after treatment, Visual Analogue Scale (VAS) and Harris score were compared between two groups.VAS scores were 67.83 +/- 8.48 and 55.83 +/- 9.66 before and after treatment in electroacupuncture group, and were 68.67 +/- 8.09 and 61.50 +/- 7.78 in medication group separately. VAS pain scores after treatment were reduced remarkably in two groups (both P0.001), but the score was reduced much more remarkably in electroacupuncture group as compared with medication group. In electroacupuncture group, after treatment, Harris total score, the single scores of joint pain, function and motion range increased apparently as compared with those before treatment (all P0.001). In medication group, after treatment, Harris total score and pain score increased remarkably as compared with those before treatment (both P0.001). Harris total score, pain score and function score after treatment in electroacupuncture group increased much more remarkably as compared with those in medication group (all P0.05).Electroacupuncture can treat effectively hip osteoarthritis, relieve joint pain and improve joint function. The efficacy of it is superior to that of oral administration of Diclofenac Sodium.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results